treatment options for locally recurrent prostate cancer giuseppe simone mediterranean school of...

23
Treatment options for locally Treatment options for locally recurrent recurrent Prostate Cancer Prostate Cancer Giuseppe Simone Giuseppe Simone Mediterranean School of Oncology Roma 15-06-2012

Upload: edith-bond

Post on 24-Dec-2015

215 views

Category:

Documents


0 download

TRANSCRIPT

Treatment options for locally recurrentTreatment options for locally recurrentProstate CancerProstate Cancer

Giuseppe SimoneGiuseppe Simone

Mediterranean School of Oncology

Roma 15-06-2012

Treatment options

Local recurrence after RPRadiotherapy

ADT if N+ M+

Other options (off label)

Treatment options

Local recurrence after Radiation treatmentsSalvage RP

Salvage Cryo

Brachy (small series)

Re-radiation (off label)

Salvage RP

Feasible?Safe?Effective? Select cases!

PSA free (3-yr 75% PSA<0.2)Continence (7/32 22%)Sexual function (3/32 9%)

Treatment options

Local recurrence after Radiation treatmentsSalvage RP

Salvage Cryo

Brachy (small series)

Re-radiation (off label)

p: ns

Treatment options

Local recurrence after Radiation treatmentsSalvage RP

Salvage Cryo

Salvage HIFU

Brachy (small series)

Re-radiation (off label)

Our experienceJan 2009 - Jan 2011

28 salvage cryo (radiorecurrent PCa)

Median age 73 (IQR 70-76)

Minimum follow-up 15 months

All patients underwent biopsy, and 18 F-choline PET-CT scan

4 cases underwent inguinal LNd excluded (pN+)

Patients characteristics

7 cases not receiving ADTMedian PSA 4.11ng/mL (IQR 1.3-5)Mean Gleason score 7.4 (range 6-9)

17 cases receiving ADT Median PSA 3.13 ng/mL (IQR 1.1-6.1)

Any of these successfully discontinued ADT!

PSA free survival 24-mo (Phoenix criteria) 56%

21-mo not ADT 65.6% 21-mo under ADT 57.6%

24-mo (ASTRO criteria) 53.6% 21-mo not ADT 80% 21-mo under ADT 60%

Local recurrence Biopsy at physician discretion! 2 positive out of 6 performed 1 seminal vesicle recurrence at 18F-chol PET-CT

Bifecta in patients not receiving ADT

72%

18 F-choline PET-CT

No report on nodal or distant metastasis

A step forward “biochemical recurrence”

In our series 2 cases of nodal recurrences4 cases with preoperative evidence of pos nodes

confirmed by hystology

Preop CT and bone scan negative

3 mo PSA 1 6 mo PSA 2

PET-CT Stereotaxic RT and ADT

32 mo PSA 0.8

Complications

Urinary Incontinence 20%

Rectal fistula 4%Previous simple prostatectomy and RT

Sloughing and AUR requiring TURP 12.5%

Hot Topics

Seminal Vesicles

Discontinuing ADT?N+? M+?2-yr ADT after adjuvant RT recommended

Sloughed tissue and AUR requiring TURP 12.5%

YesLow complication rate

Minimally invasive treatment

Learning curve salvage cryo vs salvage RP

Patients selection!!!Previous TURP-simple prostatectomy

Bifecta outcome >70%

Buts Cancer control lower than salvage RP

Pts receiving ADT should not discontinue it

Preoperative staging limits (rule out N+/M+) 18 F chol PET-CT has not 100% accuracy

Bifecta-ASTRO-Phoenix can not be compared with undetectable PSA after RP

Standardize outcome evaluation

Patient counseling

Salvage RP is the radical treatmentHealthy pts with life expectancy > 10yrs should be

counseled accordingly…

Local recurrence can be successfully treated with recryo or with ADT

10 yr Cancer specific survival 90%

Treatment options

Local recurrence after Radiation treatmentsSalvage RP

Salvage Cryo

Salvage HIFU

Brachy (small series)

Re-radiation (off label)

Patient counseling

Salvage RP is the radical treatmentHealthy pts with life expectancy > 10yrs should be

counseled accordingly…

Local recurrence can be successfully treated with recryo or with ADT

10 yr Cancer specific survival 90%